(Q35167731)

6 August 2017

1 reference

title

Node negative breast cancer. (English)

1 reference

6 August 2017

O'Reilly SM

1

1 reference

6 August 2017

Richards MA

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 1990

1 reference

6 August 2017

1 reference

6 August 2017

volume

300

1 reference

6 August 2017

issue

6721

1 reference

6 August 2017

page(s)

346-348

1 reference

Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG study

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662130

Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662130

Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662130

The relationship between histological grade, oestrogen receptor status, events and survival at 8 years in the NATO ('Nolvadex') trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662130

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662130

A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662130

Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662130

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662130

Relationship between oestrogen-receptor content and histological grade in human primary breast tumours

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662130

Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662130

Management and survival of female breast cancer: results of a national survey by the American College of Surgeons

13 July 2018

1 reference

12 December 2020

Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors

1 reference

12 December 2020

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry

1 reference

12 December 2020

Progesterone and estrogen receptors as prognostic variables in breast cancer

1 reference

12 December 2020

Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

1 reference

12 December 2020

Short perioperative versus long-term adjuvant chemotherapy

1 reference

12 December 2020

Breast carcinoma cell kinetics, morphology, stage, and host characteristics. A thymidine labeling study

1 reference

12 December 2020

Clinical trials on adjuvant chemotherapy for breast cancer

1 reference

12 December 2020

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

1 reference

12 December 2020

Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.300.6721.346

1 reference

6 August 2017

1 reference

6 August 2017

1 reference